Product Name	Docetaxel
Assay	99%
Test Method	HPLC
Appearance	White Crystalline Powder
CAS	114977-28-5
Molecular Formula	C43H53NO14

Docetaxel is a clinically well established anti-mitotic chemotherapy medication used mainly for the treatment of breast, ovarian, and non-small cell lung cancer. Docetaxel has an approved claim for treatment of patients who have locally advanced, or metastatic breast or non small-cell lung cancer who have undergone anthracycline-based chemotherapy and failed to stop cancer progression or relapsed.

Administered as a one-hour infusion every three weeks generally over a ten cycle course, docetaxel is considered better than doxorubicin, paclitaxel and fluorouracil as a cytotoxic antimicrotubule agent.

1.It is a clinically well established anti mitotic chemotherapy medication (that is, it interferes with cell division).

2.It is used mainly for the treatment of breast, ovarian, and non-small cell lung cancer.

3.It has an FDA approved claim for treatment of patients who have locally advanced, or metastatic breast or non small-cell lung cancer who have undergone anthracycline based  chemotherapy and failed to stop cancer progression or relapsed. An European  approval  docetaxel for use in hormone-refractory prostate cancer.

4.It is considered better than doxorubicin, paclitaxel and fluorouracil as a cytotoxic antimicrotubule.